InsidersTradesSigma
Track the BIO-GENE TECHNOLOGY LTD stock price and the full insider trade history of the company, a listed issuer based in Australia. Shares are quoted on the AU market, under the authority of ASX. Market capitalisation: €8.3m. The latest transaction was reported on 27 August 2026 (Change in Substantial Holding). Every trade is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
BIO-GENE TECHNOLOGY LTD is a company focused on developing biotechnology solutions. It is listed on the XASX market.